Gefitinib Approved for NSCLC, Atezolizumab Shrinks Bladder Tumors, New Treatment Advances in Multiple Myeloma - 100280

Spotlight
Video

Gefitinib Approved for NSCLC, Atezolizumab Shrinks Bladder Tumors, New Treatment Advances in Multiple Myeloma

onclivetv has 407 videos Subscribe Here

Loading........
Description: Laura Jones an the approval of gefitinib for EGFR-mutant lung cancer, results from a phase II study of atezolizumab in bladder cancer, and new treatment advancements in multiple myeloma.
Shared By : onclivetv
Posted on : 07/21/15
Added : 3 years ago